Vext Science ( (VEXTF) ) has released its Q2 earnings. Here is a breakdown of the information Vext Science presented to its investors.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Vext Science, Inc. is a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, specializing in cultivation, manufacturing, and retail of cannabis products, including the Vapen™ brand.
In its latest financial results for Q2 2025, Vext Science reported a record quarterly revenue of $13.4 million, marking a 59% increase year-over-year. The company also achieved a strong cash flow margin of 31%, driven by growth in Ohio and disciplined operations in Arizona.
Key financial highlights include an adjusted EBITDA of $4.1 million, which more than tripled compared to Q2 2024, and an operating cash flow of $4.2 million. Vext’s strategic expansion in Ohio is progressing well, with plans to reach the state dispensary license cap by early 2026, positioning the company for continued growth in the adult-use market.
Looking ahead, Vext Science aims to maintain its momentum by focusing on strong operating cash flow, enhancing its balance sheet, and delivering long-term shareholder value. The company’s disciplined approach and scalable operations are expected to support its growth trajectory in its core markets.